Literature DB >> 7709941

The burden of osteoporosis: cost.

R Lindsay1.   

Abstract

Osteoporotic fractures are generally assumed to be a major public health problem in the western world. Cost calculations are based primarily on hip fractures, which are easy to count since most require hospital admission and surgical intervention. The estimates of cost, which are $10-20 billion annually in the United States to $0.3 billion in England and Wales are therefore likely to be underestimates of the total cost of the disease. As populations age throughout the world, the costs worldwide can only increase, and estimates are staggering. Within 50 years the cost of hip fracture alone in the United States may exceed $240 billion. In some countries there appears also an age-specific increase in incidence that will only compound the problem. It is not clear to what extent therapeutic interventions can control the possible epidemic of fractures in the next century.

Entities:  

Mesh:

Year:  1995        PMID: 7709941     DOI: 10.1016/s0002-9343(05)80038-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  14 in total

1.  Training to reduce postural sway and increase functional reach in the elderly.

Authors:  M E Rogers; J E Fernandez; R M Bohlken
Journal:  J Occup Rehabil       Date:  2001-12

2.  A fractured service: the latest advice on osteoporosis.

Authors:  Alun Cooper
Journal:  Br J Gen Pract       Date:  2009-04       Impact factor: 5.386

3.  Psychometric properties and osteoprotective behaviors among type 2 diabetic patients: osteoporosis self-efficacy scale Malay version (OSES-M).

Authors:  S A Abdulameer; S A Syed Sulaiman; M A Hassali; K Subramaniam; M N Sahib
Journal:  Osteoporos Int       Date:  2012-07-13       Impact factor: 4.507

4.  A meta-analysis of the effects of cigarette smoking on bone mineral density.

Authors:  K D Ward; R C Klesges
Journal:  Calcif Tissue Int       Date:  2001-05       Impact factor: 4.333

Review 5.  Estimation of direct unit costs associated with non-vertebral osteoporotic fractures in five European countries.

Authors:  S Bouee; A Lafuma; F Fagnani; P J Meunier; J Y Reginster
Journal:  Rheumatol Int       Date:  2006-09-05       Impact factor: 2.631

6.  Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry.

Authors:  S M Cadarette; S B Jaglal; N Kreiger; W J McIsaac; G A Darlington; J V Tu
Journal:  CMAJ       Date:  2000-05-02       Impact factor: 8.262

7.  Women's Values and Preferences Regarding Osteoporosis Treatments: A Systematic Review.

Authors:  Patricia Barrionuevo; Michael R Gionfriddo; Ana Castaneda-Guarderas; Claudia Zeballos-Palacios; Pavithra Bora; Khaled Mohammed; Khalid Benkhadra; Maria Sarigianni; Mohammad Hassan Murad
Journal:  J Clin Endocrinol Metab       Date:  2019-05-01       Impact factor: 5.958

8.  The costs of benzodiazepine-associated hospital-treated fall Injuries in the EU: a Pharmo study.

Authors:  Martien J M Panneman; Wim G Goettsch; Piotr Kramarz; Ron M C Herings
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

9.  The cost-effectiveness of risedronate treatment in Japanese women with osteoporosis.

Authors:  Hansheng Ding; Nobuo Koinuma; Matt Stevenson; Michiya Ito; Yasutake Monma
Journal:  J Bone Miner Metab       Date:  2008-01-10       Impact factor: 2.626

10.  Osteoporosis: prevalence in Taiwanese women.

Authors:  Tzay-Shing Yang; Yue-Rong Chen; Yi-Jen Chen; Cheng-Yen Chang; Heung-Tat Ng
Journal:  Osteoporos Int       Date:  2004-02-11       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.